43 results on '"Mohseni, Rashin"'
Search Results
2. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
3. A comprehensive comparison between TBI vs non-TBI-based conditioning regimen in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
4. Intra-lesion injection of activated Natural Killer (NK) cells in recurrent malignant brain tumors
5. The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial
6. An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients
7. Escalated dose donor lymphocyte infusion treatment in patients with primary immune deficiencies after HSCT with reduced-intensity conditioning regimen
8. Effect of Early Bacillus Calmette-Guerin Vaccination of Pediatric Severe Combined Immunodeficiency Patients on the Outcome of Hematopoietic Stem Cell Transplantation Using a Reduced-Intensity Conditioning Regimen
9. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia
10. Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A
11. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
12. Fanconi anemia phenotypic and transplant outcomes' associations in Iranian patients
13. Total body irradiation‐free haploidentical peripheral blood stem cell transplantation compared to related and unrelated donor transplantation in pediatrics with acute lymphoblastic leukemia
14. The Outcome of Extracorporeal Photopheresis Using Cryopreservation in Pediatric Patients with Acute and Chronic Gvhd at the Largest Children’s Medical Hospital in Iran
15. Long-term follow-up of patients with LPS-responsive beige-like anchor protein deficiency after reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: report of two cases
16. The Safety and Feasibility of Intra Surgical Cavity or intra Cerebrospinal Fluid (CSF) Injection of Haploidentical Activated NK Cells in Patients with Recurrent Glioblastoma Multiforme and Brain Tumors
17. Long-term follow-up of patients with LPS-responsive beige-like anchor protein deficiency after reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: report of two cases
18. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III
19. NK Cell–derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells
20. Adoptive NK‐cell transfer as a potential treatment paradigm for Wilms tumor: A preclinical study
21. Plerixafor Combined with G-CSF for Pediatric Autologous Hematopoietic Stem Cell Mobilization
22. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III
23. Fludarabine-based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Bone Marrow Failure Syndrome Type 3
24. Successful allogeneic stem cell transplantation with fludarabine‐based reduced intensity conditioning in bone marrow failure syndrome 4
25. An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients
26. Clinical Effects of COVID-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients
27. An optimized protocol for Isolation, Expansion and Activation of Natural Killer cells from human Adipose Tissue
28. Clinical outcome of the Intrathecal administration of the allogeneic side population Adipose Derived Mesenchymal Stem Cells in Werdnig Hoffman patients: An open-label Phase I clinical trial
29. 368 - The Outcome of Extracorporeal Photopheresis Using Cryopreservation in Pediatric Patients with Acute and Chronic Gvhd at the Largest Children’s Medical Hospital in Iran
30. Fludarabine-based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Bone Marrow Failure Syndrome Type 3.
31. Emerging In Vitro 3D Tumour Models in Nanoparticle-Based Gene and Drug Therapy
32. 314 - Plerixafor Combined with G-CSF for Pediatric Autologous Hematopoietic Stem Cell Mobilization
33. Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A
34. Natural Killer Cells Treated with CD11b Expressing Subpopulation of Exosomes Show Highly Activated Phenotype Against Neuroblastoma: A Future Prospect for the Treatment of High-Risk Neuroblastoma
35. Limitations in Clinical Translation of Nanoparticle-Based Gene Therapy
36. Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
37. Will Nanotechnology Bring New Hope for Gene Delivery?
38. A rapid sonication based method for preparation of stromal vascular fraction and mesenchymal stem cells from fat tissue
39. 625 - Natural Killer Cells Treated with CD11b Expressing Subpopulation of Exosomes Show Highly Activated Phenotype Against Neuroblastoma: A Future Prospect for the Treatment of High-Risk Neuroblastoma
40. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs
41. Antitoxin Characteristic of Licorice Extract: The Inhibitory Effect on Aflatoxin Production in A spergillus parasiticus
42. Safe Transplantation Of Pluripotent Stem Cell By Preventing Teratoma Formation
43. Escalated Dose Donor Lymphocyte Infusion Treatment in Patients with Primary Immune Deficiencies After HSCT with Reduced-Intensity Conditioning Regimen.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.